Veracyte (VCYT) Q1 2020 Earnings Call Transcript
VCYT earnings call for the period ending March 31, 2020.
Veracyte
VCYT
VCYT
$62.30
$0.79
1.3%
Price as of February 24, 2021, 9:00 p.m. EST
View Interactive VCYT Charts
Veracyte Inc is engaged in the discovery, development, and commercialization of molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient treatment.
Interactive Chart
News & Analysis: Veracyte
Veracyte (VCYT) Q4 2019 Earnings Call Transcript
VCYT earnings call for the period ending December 31, 2019.
2 Top Genome Testing Stocks for Your Watch List
Genome testing is exploding on a global level; these companies are saving lives and making money.
Veracyte (VCYT) Q3 2019 Earnings Call Transcript
VCYT earnings call for the period ending September 30, 2019.
Veracyte (VCYT) Q2 2019 Earnings Call Transcript
VCYT earnings call for the period ending June 30, 2019.
Veracyte (VCYT) Q1 2019 Earnings Call Transcript
VCYT earnings call for the period ending March 31, 2019.
Veracyte Inc (VCYT) Q4 2018 Earnings Conference Call Transcript
VCYT earnings call for the period ending December 31, 2018.
Here's Why Veracyte Jumped 22.5% Higher Today
The genomic test maker posted a mighty fine third quarter.
Why First Solar, Veracyte, and KB Home Jumped Today
Stocks plunged Wednesday after Fed Chair Janet Yellen surprised the market with hints of a sooner-than-expected rate increase, but these stocks still posted strong gains. Find out more about what made these stocks soar.
Why Veracyte Inc. Shares Stormed Higher
Veracyte shares get a free pass after reporting its third-quarter earnings results.
